AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Inhaled Pulmonary Vasodilators in Respiratory Diseases
Exploring the efficacy of inhaled vasodilators in severe ARDS, COPD, and pulmonary hypertension, citing studies on nitric oxide in COPD and isoprost in COPD and pH. The chapter also discusses the FDA approval of inhaled treprostinil for interstitial lung disease based on a 2021 trial's positive outcomes.